New 'Long COVID' Study Could Lead to Future Treatment Options

New 'Long COVID' Study Could Lead to Future Treatment Options

New 'Long COVID' Study , Could Lead to Future , Treatment Options.

BBC reports that people experiencing "long COVID" have evidence of inflammation in their blood, which could lead to further understanding and potential treatments.

A new study in the United Kingdom found the presence of certain proteins increases the risk for certain symptoms, including fatigue.

Long COVID is believed to impact millions of people around the world.

Here are some of the most common symptoms. Shortness of breath, Extreme tiredness, Brain fog.

Other symptoms of Long COVID can include sleeping problems, loss of smell and anxiety.

The latest study by the Imperial College London suggests that inflammation , "could be a common feature of long COVID after hospitalization, regardless of symptom type.".

BBC reports that the findings suggest that existing drugs used to treat other forms of inflammation, like rheumatoid arthritis, could be effective against Long COVID.

This work provides strong evidence that long Covid is caused by post-viral inflammation but shows layers of complexity, Peter Openshaw, Lead research Professor, via BBC .

We hope that our work opens the way to the development of specific tests and treatments for the various types of long Covid and believe that a 'one size fits all' approach to treatment may not work, Peter Openshaw, Lead research Professor, via BBC .

The team's findings were published in the journal 'Nature Immunology.'